ストックスクリーナーアプリを入手
15.02
0.59%
0.08
Cullinan Therapeutics Inc (CGEM) 最新ニュース
Insider sales at CGEM (NASDAQ: CGEM) include 8,000-share 10b5-1 trade - Stock Titan
Cullinan Therapeutics (NASDAQ:CGEM) Shares Down 5.6%Time to Sell? - MarketBeat
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
CGEM Reiterates by BTIG -- Price Target Maintained at $38.00 - GuruFocus
Cullinan Therapeutics (NASDAQ:CGEM) Trading 8.5% HigherHere's Why - MarketBeat
Cullinan Therapeutics (NASDAQ:CGEM) Receives "Buy" Rating from BTIG Research - MarketBeat
Cullinan Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Michaelson Jennifer - Moomoo
Cullinan wins FDA review for cancer therapy developed with Taiho - MSN
Cullinan Therapeutics: Cash-Rich With A Major 2027 FDA Catalyst (NASDAQ:CGEM) - Seeking Alpha
H.C. Wainwright Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Research Analysts Issue Forecasts for CGEM Q1 Earnings - MarketBeat
Cullinan Therapeutics (CGEM) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $36 - Moomoo
A Quick Look at Today's Ratings for Cullinan Therapeutics(CGEM.US), With a Forecast Between $30 to $38 - Moomoo
Cullinan Therapeutics' (CGEM) "Buy" Rating Reaffirmed at BTIG Research - MarketBeat
CGEM Maintained by HC Wainwright & Co. -- Price Target Raised to $30 - GuruFocus
HC Wainwright Forecasts Strong Price Appreciation for Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat
Cullinan Therapeutics Inc files for mixed shelf offering - marketscreener.com
Cullinan,Taiho win FDA review for cancer therapy (CGEM:NASDAQ) - Seeking Alpha
CGEM Secures FDA Acceptance for Zipalertinib NDA - GuruFocus
Cullinan Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers - Moomoo
Cullinan Therapeutics (NASDAQ: CGEM) launches $200M ATM with TD Cowen - Stock Titan
Cullinan Therapeutics NDA for zipalertinib in advanced NSCLC accepted by FDA - Traders Union
Cullinan Therapeutics | ARS: Annual Report to Security Holders - Moomoo
Cullinan Therapeutics | DEF 14A: Definitive information statements - Moomoo
Cullinan Therapeutics | DEFA14A: Others - Moomoo
FDA starts review of new lung cancer drug, decision due Feb. 2027 - Stock Titan
Cullinan Therapeutics (CGEM) outlines 2026 virtual annual meeting - Stock Titan
Cullinan Therapeutics (NASDAQ:CGEM) Trading 6.2% HigherStill a Buy? - MarketBeat
We're Hopeful That Cullinan Therapeutics (NASDAQ:CGEM) Will Use Its Cash Wisely - Sahm
Cullinan Therapeutics (CGEM): Wedbush Raises Price Target to $36 - GuruFocus
Is Cullinan (CGEM) stock showing weakness (+2.17%) 2026-04-18Professional Trade Ideas - Xã Châu Thành
Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Analyzing the 112.72% Potential Upside - DirectorsTalk Interviews
Patterns Watch: Can Bausch Health Companies Inc expand into new markets - baoquankhu1.vn
Macro Review: Can Cullinan Therapeutics Inc benefit from deglobalization2026 Biggest Moves & Community Verified Watchlist Alerts - baoquankhu1.vn
Is Cullinan (CGEM) Stock priced for growth | Price at $14.49, Down 0.31%Safe Entry Stocks - Xã Vĩnh Công
Signal Recap: Whats the RSI of Cullinan Therapeutics Inc stock2026 Highlights & Real-Time Sentiment Analysis - baoquankhu1.vn
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is Cullinan (CGEM) Stock better than industry peers | Price at $14.47, Down 2.62%Breakout Signals - Xã Vĩnh Công
JonesTrading Sticks to Their Buy Rating for Cullinan Management (CGEM) - The Globe and Mail
Weekly Earnings: What is Cullinan Therapeutics Incs valuation compared to sectorWeekly Trading Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
JonesTrading Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $36 - Moomoo
Bull Run: Whats the profit margin of Cullinan Therapeutics Inc2026 Fundamental Recap & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Cullinan Therapeutics (NASDAQ:CGEM) Shares Up 6.3%What's Next? - MarketBeat
Will Cullinan (CGEM) Stock Grow in 2026 | Price at $15.45, Up 7.07%Price Momentum - Xã Thanh Hà
Can Cullinan Therapeutics Inc outperform under higher oil prices2026 Setups & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
CGEM SEC FilingsCullinan Oncology Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Cullinan Therapeutics (NASDAQ:CGEM) versus Genprex (NASDAQ:GNPX) Head to Head Comparison - defenseworld.net
Vanguard disaggregates holdings; reports 0 shares of Cullinan Therapeutics (CGEM) - Stock Titan
Volume Summary: Will Cullinan Therapeutics Inc benefit from AI trends2026 Fed Impact & Capital Protection Trade Alerts - baoquankhu1.vn
Cullinan Therapeutics | SCHEDULE 13G/A: Others - Moomoo
Clear Street reiterates Cullinan Oncology stock rating on Gilead deal validation - Investing.com
Potential of Cullinan Therapeutics (CGEM) Highlighted by Recent Acquisition - GuruFocus
Swing Trade: Does Cullinan Therapeutics Inc have strong EBITDA marginsMarket Risk Analysis & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Cullinan Therapeutics to lead new discussions on next-generation immune therapies - Traders Union
Decliners Report: What is Cullinan Therapeutics Incs valuation compared to sector2026 PostEarnings & Target Return Focused Picks - baoquankhu1.vn
Rate Cut: Whats the RSI of Cullinan Therapeutics Inc stockMarket Activity Summary & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Cullinan Therapeutics flags 2026 as “defining year” at Leerink, tees up key CLN-978/CLN-049 data - MarketBeat
0.78%
3.01%
大文字化:
|
ボリューム (24 時間):